A new 2-ml Beef Friendly vaccine for the protection against the black-leg, malignant edema, black disease, clostridium sordellii infections, enterotoxaemia and enteritis caused by Cl. perfringens types C and D. 2-ml subcutaneously, repeat in 4 to 6 weeks, boost annually.

American Livestock Supply, Inc. has taken great care in assembling this label information. But, due to the possibility of human error or manufacture label changes, American Livestock Supply, Inc. disclaims responsibility for use or misuse of this product. Before use, always read and follow the manufacturer's label on the physical product.

> ULTRACHOICE7250 cattle doses 500 mL500 sheep doses.Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D. Bacterin-Toxoid.For veterinary use only.

UltraChoice™ 7For use in healthy cattle and sheep as an aid in preventing blackleg caused by Cl. chauvoei; malignant edema caused by Cl. septicum; black disease caused by Cl. novyi; gas-gangrene caused by Cl. sordellii; and enterotoxemia and enteritis caused by Cl. perfringens types B, C, and D. Although Cl. perfringens type B is not a significant problem in North America, immunity is provided by the beta toxoid of type C and the epsilon toxoid of type D. This product consists of killed, standardized cultures of Clostridium chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, and Cl. perfringens types C and D, with a special, water-soluble adjuvant (Stimugen™).

DIRECTIONS: Shake well. Cattle: Aseptically administer 2 mL. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (SC) under the skin. Healthy cattle should receive 2 doses administered 4–6 weeks apart. Sheep: Aseptically administer 1 mL subcutaneously in the neck, followed by a second dose 4–6 weeks later. Annual revaccination with a single dose is recommended.

PRECAUTIONS: Store at 2?–7?C. Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Contains formalin as preservative. Temporary local swelling at injection site may occur after administration. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

Technical inquiries should be directed to Pfizer Animal Health Technical Services, (800) 366-5288 (USA), (800) 461-0917 (Canada).
U.S. Veterinary License No. 189
Pfizer Animal Health
Exton, PA 19341, USA
Div. of Pfizer Inc
NY, NY 10017